Study: Antibody for severe hemophilia a may reduce injections needed to prevent bleeding

(American Society of Hematology) An antibody engineered to prevent excessive bleeding in patients with severe hemophilia A may be safe and effective, and require fewer injections than existing options, according to a first-in-human study of the treatment published online today in Blood, the Journal of the American Society of Hematology.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news